The inclusion of semaglutide as an eligible expense for HSA/FSA holders marks a significant milestone in healthcare finance
Under proper medical supervision, it provides a science-backed approach to reducing appetite and improving long-term metabolic health
LaccID was generated through 11 rounds of directed evolution from an ancestral fungal laccase and catalyzes one-electron oxidation of diverse aromatic substrates using O 2 instead of toxic H 2 O 2
The first case study of successful treatment of HS with a GLP-1 agonist, liraglutide was published in 2017
Koltzenburg, M., Stucky, C
Discussion In this report, 17% of a large cohort of children with ASD demonstrated consistent elevations in short-chain and long-chain, but not medium-chain, acyl-carnitines